- Visibility 381 Views
- Downloads 0.9k Downloads
- Permissions
- DOI 10.18231/j.ijooo.v.11.i.2.3
-
CrossMark
Periocular basal cell carcinoma: A comprehensive narrative review on pathogenesis, diagnosis, and management
- Author Details:
-
Ankit Sanjay Varshney *
-
Debanjali Bhattacharjee
Ankit Sanjay Varshney *
Debanjali Bhattacharjee
Basal cell carcinoma (BCC) is the most common malignancy affecting the eyelid and periocular region, comprising over 80% of all eyelid tumors. While BCC rarely metastasizes, its potential for local invasion into critical ocular structures can result in significant morbidity, including vision loss, disfigurement, and functional impairment. Given the anatomical complexity of the periocular area, early diagnosis and precise intervention are essential.
This narrative review aims to provide a comprehensive and ophthalmology-specific overview of periocular BCC, encompassing its epidemiology, pathogenesis, histopathology, diagnostic strategies, and management options. The review also highlights current challenges and proposes future directions in improving care for this increasingly common malignancy.
A literature search was conducted using PubMed, Scopus, and Google Scholar for English-language articles published between January 2010 and April 2024. Keywords included “basal cell carcinoma,” “eyelid tumor,” “periocular BCC,” “Mohs surgery,” “Hedgehog pathway,” and “vismodegib.” Approximately 80 peer-reviewed articles were included based on clinical and scientific relevance.
Nodular BCC is the most prevalent histological subtype in the periocular region, followed by infiltrative and morpheaform types, which have higher recurrence risks. Diagnosis is often delayed due to resemblance to benign lesions. Mohs micrographic surgery offers >99% cure rates for high-risk cases. For advanced or unresectable cases, systemic therapies such as Hedgehog pathway inhibitors and immunotherapy provide emerging treatment options.
Periocular BCC exemplifies a low-mortality but high-morbidity malignancy where early detection, multidisciplinary collaboration, and subtype-specific management can significantly impact visual outcomes and quality of life. Future efforts should focus on diagnostic innovation, outcome measurement, and global awareness.
References
- McDaniel B, Steele RB. Basal Cell Carcinoma. [Updated 2024 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 . Available from: https://www.ncbi.nlm.nih.gov/books/NBK482439/
- Naik PP, Desai MB. Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management. Oncol Ther. 2022;10(2);317–35.
- Shi Y, Jia R, Fan X. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment. Onco Targets Ther. 2017;10:2483–9. 56 Varshney and Bhattacharjee / IP International Journal of Ocular Oncology and Oculoplasty 2025;11(2):50-56
- Knecht-Gurwin K, Stefaniak AA, Chlebicka I, Szepietowski JC. Basal Cell Carcinoma: Comprehensive Review with Emphasis on Scar Tissue Manifestation and Post-Vaccination Incidence. Biomedicines. 2024;12(8):1769.
- Baba PUF, Hassan AU, Khurshid J, Wani AH. Basal Cell Carcinoma: Diagnosis, Management and Prevention. J Mol Pathol. 2024;5(2):153–70.
- Ratner D, Peacocke M, Zhang H, Ping XL, Tsou HC. UV-specific p53 and PTCH mutations in sporadic basal cell carcinoma of sun- exposed skin. J Am Acad Dermatol. 2001;44(2):293–7.
- Grossman L. Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ Health Perspect. 1997;10(Suppl 4):927–30.
- Șerbănescu MS, Bungărdean RM, Georgiu C, Crișan M. Nodular and Micronodular Basal Cell Carcinoma Subtypes Are Different Tumors Based on Their Morphological Architecture and Their Interaction with the Surrounding Stroma. Diagnostics (Basel, Switzerland). 2022;12(7):1636.
- Kasumagic-Halilovic E, Hasic M, Ovcina-Kurtovic N. A Clinical Study of Basal Cell Carcinoma. Med Arch. 2019;73(6);394–98.
- Furdova A, Kapitanova K, Kollarova A, Sekac J. Periocular basal cell carcinoma - Clinical perspectives. Oncol Rev. 2020;14(1);420.
- Tan ST, Ghaznawie M, Heenan PJ, Dosan R. Basal Cell Carcinoma Arises from Interfollicular Layer of Epidermis. J Oncol. 2018:3098940.
- Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013;4(1):12–7.
- Milenković AD, Milenković V, Petrovic M, Tomic A, Matejic A, Brkic N, et al. Infiltrative Basal Cell Carcinoma of the Head: Factors Influencing Bone Invasion and Surgical Outcomes. Life (Basel, Switzerland). 2025;15(4);551.
- Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167-79.
- Deepthi G, Shyam NDVN, Kumar GK, Narayen V, Paremala K, Preethi P. Characterization of perineural invasion in different histological grades and variants of oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2020;24(1):57–63.
- Velazquez EF, Ayala G, Liu H, Chaux A, Zanotti M, Torres J, et al. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol. 2008;32(7):974–9.
- Caviglia M, Kaleci S, Frascione P, Teoli M, Fargnoli MC, Pellacani G, et al. A Systematic Review and Meta-Analysis of Ocular and Periocular Basal Cell Carcinoma with First-Time Description of Dermoscopic and Reflectance Confocal Microscopy Features of Caruncle Basal Cell Carcinoma. Diagnostics. 2025;15(10):1244.
- Erripi K, Paussen D, Svedberg K. Results of Mohs' Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience. Acta Dermato-Venereologica. 2024;104:15765.
- Prickett KA, Ramsey ML. Mohs Micrographic Surgery. [Updated 2023 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441833/
- Quazi SJ, Aslam N, Saleem H, Rahman J, Khan S. Surgical Margin of Excision in Basal Cell Carcinoma: A Systematic Review of Literature. Cureus, 2020;12(7):e9211.
- Lien, M. H., Sondak, VK. Nonsurgical treatment options for Basal cell carcinoma. J Skin Cancer. 2011;571734.
- Paoli J, Gyllencreutz JD, Fougelberg J, Backman EJ, Modin M, Polesie S, et al. Nonsurgical Options for the Treatment of Basal Cell Carcinoma. Dermatol Pract Concept. 2019;9(2):75–81.
- Silapunt S, Chen L, Migden MR. Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness. Therap Adv Med Oncol. 2016;8(5):375–82.
- Dummer R, Ascierto PA, Basset-Seguin N, Dréno B, Garbe C, Gutzmer R, et al. Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: A joint expert opinion. J Eur Acad Dermatol Venereol. 2020;34(9):1944–56.
- North VS, Starks VS, Lee NG. Basal Cell Carcinoma Masquerading as a Chalazion in a 27 -Year-Old Woman. JAMA Ophthalmol. 2019;137(7):e185435.